Halofuginone inhibits neointimal formation of cultured rat aorta in a concentration-dependent fashion in vitro

Heart and Vessels

Volumn 13, Issue 1, 1998, Pages 18-23

  Liu, Kexiang ^a   Sekine, S ^a   Goto, Y ^a   Iijima, K ^a   Yamagishi, I ^a   Kondon, K ^a   Matsukawa, M ^a   Abe, T ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Halofuginone; Neointimal formation; Organ culture; Rat aorta

Indexed keywords

COCCIDIOSTATIC AGENT; HALOFUGINONE;

ANIMAL TISSUE; AORTA INTIMA; ARTICLE; DOSE RESPONSE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; TISSUE CULTURE;

EID: 0031649536     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02750639     Document Type: Article

References (24)

1. Dilley RJ, McGeachie JK, Prendergast FJ (1988) A review of the histological changes in vein to artery grafts, with particular reference to intimal hyperplasia. Arch Surg 123:691-696
2. Angelini GD, Newby AC (1989) The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 10:273-280
3. Forrester JS, Fishbein M, Helfant R, Fagin J (1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 17:758-769
4. Brady AJB, Warren JB (1991) Angioplasty and restenosis. Br Med J 303:729-730
5. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314:488-500
6. Solamon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P (1991) Human coronary transplantation-associated arteriosclerosis - evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138:791-798
7. The Multicenter European Research Trial With Gilazapril After Angioplasia to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group (1992) Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutanous transluminal coronary angioplasia? Results of the MERCATOR study: a multicenter randomized, double-blind placebo-controlled trial. Circulation 86:100-110
8. 2-receptor blockade. Circulation 84:1568-1580
9. Faxon D, Spiro T, Minor S, Douglas J, Cote G, Dorosti K, Gottlieb R, Califf R, Topol E, Gordon J (1992) Enoxaparin, a low molecular weight heparin, in the prevention of restenosis after angioplasia: results of a double blind randomized trial (abstract). J Am Coll Cardiol 19 (suppl A): 258A
10. Granot I, Halevy O, Hurwitz S, Pines M (1993) Halofuginone: an inhibitor of collagen type I synthesis. Biochim Biophys Acta 1156:107-112
11. Halevy O, Nagler A, Levi-Schaffer F, Genina O, Pines M (1996) Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease as scleroderma patients: effect of halofuginone. Biochem Pharmacol 52:1057-1062
12. Nagler A, Miao HQ, Aingorn H, Pines M, Genina O, Vlodavsky I (1997) Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. Arteriosclerosis Thrombosis Vasc Biol 17:194-202
13. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC (1990) Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 137:1401-1410
14. Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after artery injury. Lab Invest 49:327-333
15. Clowes AW, Schwartz SM (1985) Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 56:139-145
16. Gotlieb AI, Boden P (1984) Porcine aortic organ culture: a model to study the cellular response to vascular injury. In Vitro 20:535-542
17. Edward WY, Koo, Avrum I, Gotlieb (1991) Neointimal formation in the porcine aortic organ culture. Lab Invest 64:743-753
18. Holt CM, Francis SE, Roger S, Gadsdon PA, Taylor T, Clelland C, Soyombo A, Newby AC, Angelini GD (1992) Intimal proliferation in an organ culture of human internal mammary artery. Circ Res 26:1189-1194
19. Gabbiani G, Rungger BE, Chastonay C, Franke WW (1982) Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest 47:265
20. Boudrean N, Myers C, Bissell MJ (1995) From laminin to lamin: regulation of tissue-specific gene expression by the ECM. Trends Cell Biol 5:1-4
21. Yamamoto M, Yamamoto K, Noumura T (1993) Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp Cell Res 204:121-129
22. Levi-Schaffer F, Nagler A, Slavin S, Knopov V, Pines M (1995) Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. J Invest Dermatol 106:84-88
23. Choi ET, Callow AD, Sehgal NL, Brown DM, Ryan US (1995) Halofuginone, a specific Type I collagen inhibitor, reduces anastomotic intimal hyperplasia. Arch Surg 130:257-261
24. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Keneda Y, Ogihara T, Dzau VJ (1993) Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 90:8474-8478